SECsense Logo

Verastem, Inc. 8-K Report: Key Updates for Investors as of January 13, 2025

$VSTM
Form 8-K
Filed on: 2025-01-13
Source
Verastem, Inc. 8-K Report: Key Updates for Investors as of January 13, 2025

Here are the key pieces of information extracted from the financial report section provided:

  1. Filing Type: The document is an 8-K report, which is typically used to announce major events that shareholders should know about.
  2. Entity Information:
  • Company Name: Verastem, Inc.
  • CIK: 0001526119
  • SEC File Number: 001-35403
  • EIN: 27-3269467
  • Address: 117 Kendrick Street, Suite 500, Needham, MA 02494
  • Phone Number: 781-292-4200
  1. Stock Information:
  • Common Stock: The company has common stock with a par value of $0.0001 per share.
  • Ticker Symbol: VSTM (traded on NASDAQ).
  1. Report Date: The report is dated as of January 13, 2025.
  2. Context: The context for the data is specified as "AsOf2025-01-13," indicating that the information is relevant as of that date.
  3. Currency: The report uses USD as the currency for financial figures.
  4. Units of Measure: The report indicates the use of shares for stock transactions.

Insights:

  • The filing is a significant event for Verastem, Inc., and could include updates regarding corporate governance, financial performance, or other important business developments.
  • The specific date of the report being in the future (January 13, 2025) suggests that it may be part of a forward-looking disclosure or a planned announcement concerning upcoming business activities or financial results.
  • The company operates in the biotechnology sector, as suggested by the name "Verastem," implying a focus on therapeutic developments, which could be of interest to investors and stakeholders monitoring advancements in this field.